Major Study Points to COVID-19 Treatment; ‘Game Changer?”

COVID-19 remains a global crisis, particularly since we are moving into the more critical stage ("restart economy"), so please feel free to share this with anyone interested. Last evening, the world learned a Univ. of Chicago's Phase 3 trial of Gilead's (GILD) Remdesivir shows significant promise.
Remdesivir has been talked about for some time so I understand the skepticism, but the market has jumped 3% at the prospect.

Policymakers say a vaccine is key, but that could be six to 18 months awa...

Finish reading this report for free

Enter your email and we'll send the paywall-free report directly to your inbox

Articles Read: 1/2

In addition to your unlocked report, you will receive our weekly market newsletter Fundstrat Snapshot, as well as occasional updates and offers from Fundstrat Direct. You can unsubscribe at any time.

Get unlimited access to Tom Lee's Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Events

Trending tickers in our research